M Li1, F Lv1, Z Zhang2, W Deng3, Y Li4, Z Deng5, Y Jiang1, O Wang1, X Xing1, L Xu6, W Xia7. 1. Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Wangfujing Street, Beijing, 100730, China. 2. Department of Osteoporosis, Sixth People's Hospital, Shanghai Jiaotong University, No. 600 Yishan Road, Shanghai, 200233, China. 3. Department of Geriatrics, General Hospital of Guangzhou Military Command, No. 111 Liuhua Road, Guangzhou, 510010, China. 4. Department of Laboratory, Hubei General Hospital, No. 238 Jiefang Road, Wuhan, 430060, China. 5. Department of Orthopedics, The Second Affiliated Hospital of Chongqing Medical University, No. 76 Linjiang road, Chongqing, 400010, China. 6. Department of Obstetrics and Gynecology, Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Wangfujing Street, Beijing, 100730, China. 7. Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Wangfujing Street, Beijing, 100730, China. xiaweibo8310@163.com.
Abstract
UNLABELLED: A normal reference value of parathyroid hormone (PTH) was established for the first time in a large sample of healthy Chinese subjects by completely excluding interference of vitamin D deficiency. A high PTH level correlated significantly with an elevated bone turnover and a reduced bone mineral density (BMD). INTRODUCTION: The aims of this study are to establish a normal reference value for serum PTH and to evaluate the effect of parathyroid gland status on bone turnover and BMD. METHODS: Our cross-sectional study included 1436 healthy individuals from 5 different Chinese cities. Concentrations of serum PTH, 25-hydroxyvitamin D (25OHD), procollagen I N-terminal peptide (P1NP, a bone formation marker), and carboxyl-terminal telopeptide of type I collagen (β-CTX, a bone resorption marker) were measured by electrochemiluminescence immunoassay. BMD was measured by dual-energy X-ray absorptiometry. The relation of PTH concentration to age, gender, height, and weight was examined. Reference values of PTH were established for all subjects and for subjects categorized by serum 25OHD concentrations. Correlations of PTH levels with bone turnover biomarkers and BMD were statistically analyzed. RESULTS: Reference values of PTH were 8.84-69.95 pg/mL in all the subjects and 7.48-60.73 and 5.83-56.78 pg/mL in the subjects with serum 25OHD concentrations of ≥20 and ≥30 ng/mL, respectively. Serum PTH showed a negative linear correlation with 25OHD, and the breakpoint was 18.21 ng/mL, below which the PTH level rapidly increased. The increase in PTH levels with age showed a positive linear correlation with P1NP and β-CTX concentrations and a negative linear correlation with BMD at the lumbar spines and the femoral neck. CONCLUSIONS: A reference value of PTH was established in a large sample of healthy Chinese subjects according to 25OHD status, gender, and age. A high PTH level correlated significantly with an elevated bone turnover and a reduced BMD.
UNLABELLED: A normal reference value of parathyroid hormone (PTH) was established for the first time in a large sample of healthy Chinese subjects by completely excluding interference of vitamin D deficiency. A high PTH level correlated significantly with an elevated bone turnover and a reduced bone mineral density (BMD). INTRODUCTION: The aims of this study are to establish a normal reference value for serum PTH and to evaluate the effect of parathyroid gland status on bone turnover and BMD. METHODS: Our cross-sectional study included 1436 healthy individuals from 5 different Chinese cities. Concentrations of serum PTH, 25-hydroxyvitamin D (25OHD), procollagen I N-terminal peptide (P1NP, a bone formation marker), and carboxyl-terminal telopeptide of type I collagen (β-CTX, a bone resorption marker) were measured by electrochemiluminescence immunoassay. BMD was measured by dual-energy X-ray absorptiometry. The relation of PTH concentration to age, gender, height, and weight was examined. Reference values of PTH were established for all subjects and for subjects categorized by serum 25OHD concentrations. Correlations of PTH levels with bone turnover biomarkers and BMD were statistically analyzed. RESULTS: Reference values of PTH were 8.84-69.95 pg/mL in all the subjects and 7.48-60.73 and 5.83-56.78 pg/mL in the subjects with serum 25OHD concentrations of ≥20 and ≥30 ng/mL, respectively. Serum PTH showed a negative linear correlation with 25OHD, and the breakpoint was 18.21 ng/mL, below which the PTH level rapidly increased. The increase in PTH levels with age showed a positive linear correlation with P1NP and β-CTX concentrations and a negative linear correlation with BMD at the lumbar spines and the femoral neck. CONCLUSIONS: A reference value of PTH was established in a large sample of healthy Chinese subjects according to 25OHD status, gender, and age. A high PTH level correlated significantly with an elevated bone turnover and a reduced BMD.
Entities:
Keywords:
25OHD; BMD; Bone turnover; P1NP; PTH; β-CTX
Authors: José L Hernández; José M Olmos; Emilio Pariente; Daniel Nan; Josefina Martínez; Javier Llorca; Carmen Valero; Eduardo Obregón; Jesús González-Macías Journal: J Clin Endocrinol Metab Date: 2013-03-01 Impact factor: 5.958
Authors: Anna Liza B Valiña-Tóth; Zongshan Lai; Wonsuk Yoo; Abdul Abou-Samra; Crystal A Gadegbeku; John M Flack Journal: Clin Endocrinol (Oxf) Date: 2009-07-28 Impact factor: 3.478
Authors: Marie Metzger; Pascal Houillier; Cédric Gauci; Jean Philippe Haymann; Martin Flamant; Eric Thervet; Jean-Jacques Boffa; François Vrtovsnik; Marc Froissart; Bénédicte Stengel; Pablo Ureña-Torres Journal: J Clin Endocrinol Metab Date: 2013-04-30 Impact factor: 5.958
Authors: Samuel Vasikaran; Cyrus Cooper; Richard Eastell; Andrea Griesmacher; Howard A Morris; Tommaso Trenti; John A Kanis Journal: Clin Chem Lab Med Date: 2011-05-24 Impact factor: 3.694
Authors: Lei Shu; Ji Ji; Qi Zhu; Guofan Cao; Andrew Karaplis; Martin R Pollak; Edward Brown; David Goltzman; Dengshun Miao Journal: J Bone Miner Res Date: 2011-05 Impact factor: 6.741
Authors: F Lv; M Ma; W Liu; X Xu; Y Song; L Li; Y Jiang; O Wang; W Xia; X Xing; Z Qiu; M Li Journal: Osteoporos Int Date: 2017-06-16 Impact factor: 4.507
Authors: P Peris; X Filella; A Monegal; N Guañabens; L Foj; M Bonet; D Boquet; E Casado; D Cerdá; A Erra; C Gómez-Vaquero; S Martínez; N Montalá; C Pittarch; E Kanterewicz; M Sala; X Suris; J L Carrasco Journal: Osteoporos Int Date: 2017-05-02 Impact factor: 4.507